Skeletal formula of <a href="https://en.wikipedia.org/wiki/aplaviroc" class="extiw" title="w:aplaviroc">aplaviroc</a> (codenamed AK-602 and GSK-873140) — a <a href="https://en.wikipedia.org/wiki/CCR5" class="extiw" title="w:CCR5">CCR5</a> receptor antagonist acting as an <a href="https://en.wikipedia.org/wiki/entry_inhibitor" class="extiw" title="w:entry inhibitor">entry inhibitor</a> that was under investigation as a treatment for <a href="https://en.wikipedia.org/wiki/HIV/AIDS" class="extiw" title="w:HIV/AIDS">HIV infection</a>.
<a href="//commons.wikimedia.org/wiki/User:Vaccinationist" title="User:Vaccinationist">Vaccinationist</a>
Own work  using: <a rel="nofollow" class="external text" href="https://pubchem.ncbi.nlm.nih.gov/compound/3001322">PubChem</a>